Status:
COMPLETED
Study of Hormonal Sideeffects in Patients Taking Levetiracetam, Carbamazepine or Lamotrigine for Epilepsy
Lead Sponsor:
Rikshospitalet University Hospital
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Epilepsy
Eligibility:
All Genders
18-45 years
Brief Summary
Some antiepileptic drugs are found to have hormonal side effects. We want to study possible hormonal side effects of the relatively new antiepileptic drug; levetiracetam and compare it to the older dr...
Detailed Description
We have previously performed long-term studies of rats treated with levetiracetam and compared them with a control group. Here we have found that levetiracetam has a probable effect on the ovaries, si...
Eligibility Criteria
Inclusion
- Having epilepsy
- Age 18- 45
- Using levetiracetam/ lamotrigine or carbamazepine in monotherapy for at least 6 months
Exclusion
- Hormonal diseases( ie; diabetes, hypo/ hyperthyroid disease)
- Use of hormonal anticonception drugs or other hormonal drugs.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00460070
Start Date
January 1 2007
End Date
March 1 2009
Last Update
July 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Neurology, Rikshospitalet Universty Hospital
Oslo, Oslo County, Norway, 0027